Breaking News Instant updates and real-time market news.

DUFRY

Dufry

$0.00 /

+ (+0.00%)

12:17
02/17/21
02/17
12:17
02/17/21
12:17

Dufry price target raised to CHF 48 from CHF 35 at UBS

UBS analyst Joern Iffert raised the firm's price target on Dufry to CHF 48 from CHF 35 and keeps a Neutral rating on the shares.

  • 09

    Mar

DUFRY Dufry
$0.00 /

+ (+0.00%)

01/27/21 Goldman Sachs
Dufry upgraded to Buy from Neutral at Goldman Sachs
11/17/20 RBC Capital
Dufry initiated with an Underperform at RBC Capital
11/04/20 Oddo BHF
Dufry downgraded to Neutral from Buy at Oddo BHF
11/02/20 UBS
Dufry price target raised to CHF 35 from CHF 34 at UBS

TODAY'S FREE FLY STORIES

General news
Fed Balance Sheet Level data reported » 16:36
02/25/21
02/25
16:36
02/25/21
16:36

Week of 2/24 Fed Balance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Select Medical announces $500M share repurchase program » 16:35
02/25/21
02/25
16:35
02/25/21
16:35
SEM

Select Medical

$26.96 /

-1.67 (-5.83%)

The board of directors of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEM Select Medical
$26.96 /

-1.67 (-5.83%)

SEM Select Medical
$26.96 /

-1.67 (-5.83%)

02/17/21 Deutsche Bank
Select Medical price target raised to $34 from $27 at Deutsche Bank
08/04/20 Deutsche Bank
Select Medical price target raised to $26 from $24 at Deutsche Bank
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
SEM Select Medical
$26.96 /

-1.67 (-5.83%)

Recommendations
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label' » 16:35
02/25/21
02/25
16:35
02/25/21
16:35
SRPT

Sarepta

$85.20 /

+0.87 (+1.03%)

After Sarepta announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRPT Sarepta
$85.20 /

+0.87 (+1.03%)

SRPT Sarepta
$85.20 /

+0.87 (+1.03%)

02/09/21 Morgan Stanley
Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
01/12/21 Citi
Sarepta downgraded to Neutral from Buy at Citi
01/11/21
Fly Intel: Top five analyst downgrades
01/11/21 UBS
Sarepta downgraded to Neutral on 'unexpected negative' results at UBS
SRPT Sarepta
$85.20 /

+0.87 (+1.03%)

SRPT Sarepta
$85.20 /

+0.87 (+1.03%)

Earnings
Zscaler sees FY21 EPS 39c-40c, consensus 38c » 16:35
02/25/21
02/25
16:35
02/25/21
16:35
ZS

Zscaler

$195.76 /

-12.01 (-5.78%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

06:05 Today Credit Suisse
Ping Identity downgraded to Neutral from Outperform at Credit Suisse
02/22/21 RBC Capital
Zscaler price target raised to $240 from $205 at RBC Capital
02/16/21 Canaccord
Zscaler initiated with a Buy at Canaccord
01/20/21
Fly Intel: Top five analyst initiations
ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

Earnings
Tracon Pharmaceuticals reports Q4 EPS (26c), consensus (41c) » 16:35
02/25/21
02/25
16:35
02/25/21
16:35
TCON

Tracon Pharmaceuticals

$9.00 /

-0.425 (-4.51%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$9.00 /

-0.425 (-4.51%)

TCON Tracon Pharmaceuticals
$9.00 /

-0.425 (-4.51%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Maxim
Tracon Pharmaceuticals initiated with a Buy at Maxim
12/04/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright
09/17/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright
TCON Tracon Pharmaceuticals
$9.00 /

-0.425 (-4.51%)

TCON Tracon Pharmaceuticals
$9.00 /

-0.425 (-4.51%)

Earnings
Park Hotels & Resorts declines to provide FY21 guidance » 16:34
02/25/21
02/25
16:34
02/25/21
16:34
PK

Park Hotels & Resorts

$21.19 /

-1.25 (-5.57%)

Given the continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PK Park Hotels & Resorts
$21.19 /

-1.25 (-5.57%)

PK Park Hotels & Resorts
$21.19 /

-1.25 (-5.57%)

12/15/20 Citi
Park Hotels & Resorts upgraded to Neutral from Sell at Citi
12/10/20 Wells Fargo
Park Hotels & Resorts upgraded to Overweight with $20 target at Wells Fargo
12/10/20 Wells Fargo
Park Hotels & Resorts upgraded to Overweight from Equal Weight at Wells Fargo
11/23/20 Jefferies
Jefferies upgrades Park Hotels & Resorts to Buy, doubles price target to $22
PK Park Hotels & Resorts
$21.19 /

-1.25 (-5.57%)

PK Park Hotels & Resorts
$21.19 /

-1.25 (-5.57%)

Earnings
Select Medical reports Q4 adjusted EPS 57c, consensus 31c » 16:34
02/25/21
02/25
16:34
02/25/21
16:34
SEM

Select Medical

$26.96 /

-1.67 (-5.83%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEM Select Medical
$26.96 /

-1.67 (-5.83%)

SEM Select Medical
$26.96 /

-1.67 (-5.83%)

02/17/21 Deutsche Bank
Select Medical price target raised to $34 from $27 at Deutsche Bank
08/04/20 Deutsche Bank
Select Medical price target raised to $26 from $24 at Deutsche Bank
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
SEM Select Medical
$26.96 /

-1.67 (-5.83%)

Earnings
iHeartMedia reports Q4 adjusted EBITDA $265M vs. $306M last year » 16:34
02/25/21
02/25
16:34
02/25/21
16:34
IHRT

iHeartMedia

$13.66 /

-0.82 (-5.66%)

Reports Q4 revenue $936M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

01/19/21 Wells Fargo
iHeartMedia price target raised to $20 from $14 at Wells Fargo
12/18/20 BofA
iHeartMedia cut to Underperform at BofA on low visibility in ad trends
12/18/20 BofA
iHeartMedia downgraded to Underperform from Neutral at BofA
07/24/20 B. Riley FBR
iHeartMedia price target raised to $11 from $8.50 at B. Riley FBR
IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

Earnings
PRA Group reports Q4 EPS 65c, consensus 62c » 16:34
02/25/21
02/25
16:34
02/25/21
16:34
PRAA

PRA Group

$36.58 /

-1.09 (-2.89%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRAA PRA Group
$36.58 /

-1.09 (-2.89%)

06/10/20 JMP Securities
PRA Group price target raised to $45 from $35 at JMP Securities
05/08/20 JMP Securities
PRA Group upgraded to Outperform from Market Perform at JMP Securities
05/08/20 JMP Securities
PRA Group upgraded to Outperform from Market Perform at JMP Securities
04/12/20 Keefe Bruyette
PRA Group upgraded to Outperform from Market Perform at Keefe Bruyette
PRAA PRA Group
$36.58 /

-1.09 (-2.89%)

Earnings
Cushman & Wakefield reports Q4 EPS 43c, consensus 35c » 16:34
02/25/21
02/25
16:34
02/25/21
16:34
CWK

Cushman & Wakefield

$16.31 /

-0.86 (-5.01%)

Reports Q4 fee revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CWK Cushman & Wakefield
$16.31 /

-0.86 (-5.01%)

CWK Cushman & Wakefield
$16.31 /

-0.86 (-5.01%)

01/25/21
Fly Intel: Top five analyst initiations
01/25/21 Goldman Sachs
Cushman & Wakefield initiated with a Neutral at Goldman Sachs
12/21/20 JPMorgan
Cushman & Wakefield price target raised to $17 from $13 at JPMorgan
09/17/20
Fly Intel: Top five analyst initiations
CWK Cushman & Wakefield
$16.31 /

-0.86 (-5.01%)

CWK Cushman & Wakefield
$16.31 /

-0.86 (-5.01%)

Earnings
Zscaler sees Q3 EPS 7c, consensus 8c » 16:34
02/25/21
02/25
16:34
02/25/21
16:34
ZS

Zscaler

$195.76 /

-12.01 (-5.78%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

06:05 Today Credit Suisse
Ping Identity downgraded to Neutral from Outperform at Credit Suisse
02/22/21 RBC Capital
Zscaler price target raised to $240 from $205 at RBC Capital
02/16/21 Canaccord
Zscaler initiated with a Buy at Canaccord
01/20/21
Fly Intel: Top five analyst initiations
ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

Earnings
Park Hotels & Resorts reports Q4 EPS (92c), consensus (90c) » 16:34
02/25/21
02/25
16:34
02/25/21
16:34
PK

Park Hotels & Resorts

$21.19 /

-1.25 (-5.57%)

Reports Q4 adjusted FFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PK Park Hotels & Resorts
$21.19 /

-1.25 (-5.57%)

PK Park Hotels & Resorts
$21.19 /

-1.25 (-5.57%)

12/15/20 Citi
Park Hotels & Resorts upgraded to Neutral from Sell at Citi
12/10/20 Wells Fargo
Park Hotels & Resorts upgraded to Overweight with $20 target at Wells Fargo
12/10/20 Wells Fargo
Park Hotels & Resorts upgraded to Overweight from Equal Weight at Wells Fargo
11/23/20 Jefferies
Jefferies upgrades Park Hotels & Resorts to Buy, doubles price target to $22
PK Park Hotels & Resorts
$21.19 /

-1.25 (-5.57%)

PK Park Hotels & Resorts
$21.19 /

-1.25 (-5.57%)

Earnings
Endo sees Q1 adjusted EPS 40c-50c, consensus 53c » 16:33
02/25/21
02/25
16:33
02/25/21
16:33
ENDP

Endo

$9.32 /

-0.55 (-5.57%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

01/19/21 Citi
Endo price target raised to $9 from $7 at Citi
01/04/21 Piper Sandler
Endo price target raised to $12 from $6 at Piper Sandler
11/23/20 Citi
Citi recommends pair trade of overweight Endo, underweight Teva
10/20/20 H.C. Wainwright
BioSpecifics downgraded to Neutral from Buy at H.C. Wainwright
ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

Earnings
Zscaler reports Q2 EPS 10c, consensus 8c » 16:33
02/25/21
02/25
16:33
02/25/21
16:33
ZS

Zscaler

$195.76 /

-12.01 (-5.78%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

06:05 Today Credit Suisse
Ping Identity downgraded to Neutral from Outperform at Credit Suisse
02/22/21 RBC Capital
Zscaler price target raised to $240 from $205 at RBC Capital
02/16/21 Canaccord
Zscaler initiated with a Buy at Canaccord
01/20/21
Fly Intel: Top five analyst initiations
ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

Earnings
A-Mark Precious Metals sees Q3 EPS $2.90-$3.20 vs. $1.61 last year » 16:33
02/25/21
02/25
16:33
02/25/21
16:33
AMRK

A-Mark Precious Metals

$27.40 /

-0.21 (-0.76%)

The Company expects net…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRK A-Mark Precious Metals
$27.40 /

-0.21 (-0.76%)

AMRK A-Mark Precious Metals
$27.40 /

-0.21 (-0.76%)

02/10/21 Roth Capital
A-Mark Precious Metals price target raised to $60 from $45 at Roth Capital
09/28/20 Roth Capital
A-Mark Precious Metals price target raised to $45 from $33 at Roth Capital
08/24/20
Fly Intel: Top five analyst initiations
08/24/20 Roth Capital
A-Mark Precious Metals initiated with a Buy at Roth Capital
AMRK A-Mark Precious Metals
$27.40 /

-0.21 (-0.76%)

  • 04
    Mar
AMRK A-Mark Precious Metals
$27.40 /

-0.21 (-0.76%)

Earnings
Endo sees Q1 adjusted EPS 40c-50c, consensus 53c » 16:33
02/25/21
02/25
16:33
02/25/21
16:33
ENDP

Endo

$9.32 /

-0.55 (-5.57%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

01/19/21 Citi
Endo price target raised to $9 from $7 at Citi
01/04/21 Piper Sandler
Endo price target raised to $12 from $6 at Piper Sandler
11/23/20 Citi
Citi recommends pair trade of overweight Endo, underweight Teva
10/20/20 H.C. Wainwright
BioSpecifics downgraded to Neutral from Buy at H.C. Wainwright
ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

Hot Stocks
StarTek names Vikash Sureka as CFO » 16:33
02/25/21
02/25
16:33
02/25/21
16:33
SRT

StarTek

$8.36 /

+0.13 (+1.58%)

Startek announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRT StarTek
$8.36 /

+0.13 (+1.58%)

06/11/20 Lake Street
StarTek price target lowered to $10 from $12 at Lake Street
06/11/20 B. Riley FBR
StarTek selloff brings attractive entry point, says B. Riley FBR
04/08/20 B. Riley FBR
StarTek price target lowered to $6 from $10.50 at B. Riley FBR
03/13/20 Lake Street
StarTek valuation compelling after strong Q4, says Lake Street
SRT StarTek
$8.36 /

+0.13 (+1.58%)

Earnings
US Ecology sees FY21 adjusted EPS 65c-88c, consensus 85c » 16:32
02/25/21
02/25
16:32
02/25/21
16:32
ECOL

US Ecology

$39.45 /

-1.52 (-3.71%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOL US Ecology
$39.45 /

-1.52 (-3.71%)

ECOL US Ecology
$39.45 /

-1.52 (-3.71%)

04/03/20 BMO Capital
US Ecology price target lowered to $37 from $50 at BMO Capital
03/04/20 UBS
US Ecology, Republic Services, Waste Management upgraded to Buy at UBS
03/04/20 UBS
US Ecology upgraded to Buy from Neutral at UBS
ECOL US Ecology
$39.45 /

-1.52 (-3.71%)

Earnings
Endo sees FY21 adjusted EPS $1.80-$2.30, consensus $2.32 » 16:32
02/25/21
02/25
16:32
02/25/21
16:32
ENDP

Endo

$9.32 /

-0.55 (-5.57%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

01/19/21 Citi
Endo price target raised to $9 from $7 at Citi
01/04/21 Piper Sandler
Endo price target raised to $12 from $6 at Piper Sandler
11/23/20 Citi
Citi recommends pair trade of overweight Endo, underweight Teva
10/20/20 H.C. Wainwright
BioSpecifics downgraded to Neutral from Buy at H.C. Wainwright
ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

Earnings
Apellis reports Q EPS 93c, consensus (75c) » 16:32
02/25/21
02/25
16:32
02/25/21
16:32
APLS

Apellis

$45.07 /

-1.155 (-2.50%)

Reports Q4 revenue $250K,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APLS Apellis
$45.07 /

-1.155 (-2.50%)

APLS Apellis
$45.07 /

-1.155 (-2.50%)

01/29/21 Baird
Apellis assumed at Outperform at Baird
12/14/20 Roth Capital
Apellis price target raised to $73 from $50 at Roth Capital
12/10/20 Cowen
Apellis price target raised to $55 from $45 at Cowen
12/04/20 JPMorgan
Apellis price target raised to $87 from $50 at JPMorgan
APLS Apellis
$45.07 /

-1.155 (-2.50%)

APLS Apellis
$45.07 /

-1.155 (-2.50%)

Earnings
Bandwidth sees 2021 non-GAAP EPS 2c-12c, consensus 35c » 16:32
02/25/21
02/25
16:32
02/25/21
16:32
BAND

Bandwidth

$161.64 /

-8.79 (-5.16%)

Sees 2021 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAND Bandwidth
$161.64 /

-8.79 (-5.16%)

BAND Bandwidth
$161.64 /

-8.79 (-5.16%)

01/27/21 Berenberg
Bandwidth initiated with a Buy at Berenberg
10/13/20 JPMorgan
Bandwidth price target raised to $190 from $170 at JPMorgan
10/13/20 Canaccord
Bandwidth price target raised to $225 from $175 at Canaccord
10/13/20 JMP Securities
Bandwidth price target raised to $206 from $180 at JMP Securities
BAND Bandwidth
$161.64 /

-8.79 (-5.16%)

  • 03
    Nov
BAND Bandwidth
$161.64 /

-8.79 (-5.16%)

Hot Stocks
Ares Management, AMP to pursue JV deal for AMP Capital's Private Markets » 16:32
02/25/21
02/25
16:32
02/25/21
16:32
ARES

Ares Management

$51.79 /

-0.43 (-0.82%)

AMP Limited and Ares…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARES Ares Management
$51.79 /

-0.43 (-0.82%)

ARES Ares Management
$51.79 /

-0.43 (-0.82%)

02/24/21 Credit Suisse
Ares Management re-initiated with a Neutral at Credit Suisse
02/12/21 Barclays
Ares Management price target raised to $58 from $56 at Barclays
01/05/21 Goldman Sachs
Ares Management downgraded to Buy from Conviction Buy at Goldman Sachs
05/28/20 BMO Capital
Ares Management upgraded to Outperform from Market Perform at BMO Capital
ARES Ares Management
$51.79 /

-0.43 (-0.82%)

ARES Ares Management
$51.79 /

-0.43 (-0.82%)

Earnings
US Ecology reports Q4 adjusted EPS 19c consensus 13c » 16:32
02/25/21
02/25
16:32
02/25/21
16:32
ECOL

US Ecology

$39.45 /

-1.52 (-3.71%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECOL US Ecology
$39.45 /

-1.52 (-3.71%)

ECOL US Ecology
$39.45 /

-1.52 (-3.71%)

04/03/20 BMO Capital
US Ecology price target lowered to $37 from $50 at BMO Capital
03/04/20 UBS
US Ecology, Republic Services, Waste Management upgraded to Buy at UBS
03/04/20 UBS
US Ecology upgraded to Buy from Neutral at UBS
ECOL US Ecology
$39.45 /

-1.52 (-3.71%)

Earnings
Endo reports Q4 adjusted EPS 75c, consensus 48c » 16:31
02/25/21
02/25
16:31
02/25/21
16:31
ENDP

Endo

$9.32 /

-0.55 (-5.57%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

01/19/21 Citi
Endo price target raised to $9 from $7 at Citi
01/04/21 Piper Sandler
Endo price target raised to $12 from $6 at Piper Sandler
11/23/20 Citi
Citi recommends pair trade of overweight Endo, underweight Teva
10/20/20 H.C. Wainwright
BioSpecifics downgraded to Neutral from Buy at H.C. Wainwright
ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

ENDP Endo
$9.32 /

-0.55 (-5.57%)

Syndicate
Groupon files to sell $250M of convertible senior notes for holders  16:31
02/25/21
02/25
16:31
02/25/21
16:31
GRPN

Groupon

$36.96 /

-1.57 (-4.07%)

 
ShowHide Related Items >><<
GRPN Groupon
$36.96 /

-1.57 (-4.07%)

GRPN Groupon
$36.96 /

-1.57 (-4.07%)

01/04/21 Barclays
Groupon assumed with an Underweight at Barclays
11/02/20 Wedbush
Groupon price target lowered to $21 from $27 at Wedbush
10/14/20 Barclays
Groupon price target lowered to $17 from $19 at Barclays
08/13/20 DA Davidson
Groupon price target raised to $36 from $32 at DA Davidson
GRPN Groupon
$36.96 /

-1.57 (-4.07%)

GRPN Groupon
$36.96 /

-1.57 (-4.07%)

GRPN Groupon
$36.96 /

-1.57 (-4.07%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.